Cargando…
SAT-254 Combination of Octreotide and Dexamphetamine to Control Weight Gain in Pediatric Patients with Hypothalamic Obesity
Hypothalamic obesity (HO) is a devastating complication, that occurs in patients with hypothalamic damage. It is characterized by polyphagia, and adynamia leading to a severe form of obesity, which is intractable to caloric restriction or lifestyle modification. HO is suggested to be a result of hyp...
Autores principales: | Reschke, Felix, Knoefler, Ralf, Smitka, Martin, Huebner, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552521/ http://dx.doi.org/10.1210/js.2019-SAT-254 |
Ejemplares similares
-
MON-254 Fragility Fracture in a Pediatric Patient with Williams-Beuren Syndrome
por: Favela, Kristin, et al.
Publicado: (2019) -
Piloting a New Approach to the Treatment of Obesity Using Dexamphetamine
por: Poulton, Alison S., et al.
Publicado: (2015) -
Clinical Perspective on Primary Angiitis of the Central Nervous System in Childhood (cPACNS)
por: Smitka, Martin, et al.
Publicado: (2020) -
SAT-054 Gigantism and Hypothalamic Obesity: Rare Endocrine Manifestations of Neurofibromatosis Type 1
por: Roberts, Richard Ogden, et al.
Publicado: (2020) -
Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
por: Elfers, Clinton Thomas, et al.
Publicado: (2011)